文献类型：期刊文献

英文题名：Advances in biomaterial-based cardiac organoids

作者：Fan, Caixia[1];He, Jiaxiong[1];Xu, Sijia[1];Yan, Junyan[1];Jin, Lifang[1];Dai, Jianwu[2];Hu, Baowei[1]

机构：[1]Shaoxing Univ, Sch Life & Environm Sci, Shaoxing 312000, Zhejiang, Peoples R China;[2]Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100080, Peoples R China

年份：2023

卷号：153

外文期刊名：BIOMATERIALS ADVANCES

收录：SCI-EXPANDED(收录号：WOS:001058882500001)、、EI(收录号：20232714342526)、Scopus(收录号：2-s2.0-85163770714)、WOS

基金：This study was supported by the National Natural Science Founda-tion of China (No. 81901266) . We also thanked the support from Shaoxing University (grant no. 20235005) .

语种：英文

外文关键词：Cardiac organoids; Biomaterials; Cardiovascular disease

外文摘要：Cardiovascular disease (CVD) is one of the important causes of death worldwide. The incidence and mortality rates are increasing annually with the intensification of social aging. The efficacy of drug therapy is limited in individuals suffering from severe heart failure due to the inability of myocardial cells to undergo regeneration and the challenging nature of cardiac tissue repair following injury. Consequently, surgical transplantation stands as the most efficient approach for treatment. Nevertheless, the shortage of donors and the considerable number of heart failure patients worldwide, estimated at 26 million, results in an alarming treatment deficit, with only around 5000 heart transplants feasible annually. The existing major alternatives, such as mechanical or xenogeneic hearts, have significant flaws, such as high cost and rejection, and are challenging to implement for large-scale, long-term use. An organoid is a three-dimensional (3D) cell tissue that mimics the characteristics of an organ. The critical application has been rated in annual biotechnology by authoritative journals, such as Science and Cell. Related industries have achieved rapid growth in recent years. Based on this technology, cardiac organoids are expected to pave the way for viable heart repair and treatment and play an essential role in pathological research, drug screening, and other areas. This review centers on the examination of biomaterials employed in cardiac repair, strategies employed for the reconstruction of cardiac structure and function, clinical investigations pertaining to cardiac repair, and the prospective applications of cardiac organoids. From basic research to clinical practice, the current status, latest progress, challenges, and prospects of biomaterial-based cardiac repair are summarized and discussed, providing a reference for future exploration and development of cardiac regeneration strategies.